A phase II, open-label trial of skin toxicity (ST) evaluation (STEPP) in metastatic colorectal cancer (mCRC) patients (pts) receiving panitumumab (pmab) + FOLFIRI or irinotecan-only chemotherapy (CT) as 2nd-line treatment (tx): Interim analysis
Year: 2008
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: E. P. Mitchell, M. E. LaCouture, H. Shearer, N. Iannotti, B. Piperdi, M. V. Pillai, F. Xu, M. Couture, M. Yassine
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2264753802